The loss of Aimmune Therapeutics under GAAP in 6 months. 2020 was $155.676 million, up 32.9% from $117.144 million in the previous year. Revenue amounted to $0.575 mln. In 1H2019, the company did not receive any revenue.
The loss of Aimmune Therapeutics under GAAP in 6 months. 2020 was $155.676 million, up 32.9% from $117.144 million in the previous year. Revenue amounted to $0.575 mln. In 1H2019, the company did not receive any revenue. 
ir.aimmune.com
English (US) 